Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05688111

Tranexamic Acid as an Intervention in Placenta Previa

Conditions: Interventional Drug in Placenta Previa

Sex: Female

Ages: 18 Years – 45 Years

Phase: NA

Enrollment: 300

Sponsor: Hawler Medical University

Location: Iraq

Summary

Antepartum hemorrhage (APH) due to placenta previa is an important cause of worldwide perinatal mortality and maternal morbidity in pregnant women

Eligibility Criteria

Inclusion Criteria:Pregnant at 24 weeks gestation and moreVaginal bleeding due to placenta previaStable hemodynamicallyAccept to participate in the trialExclusion Criteria:Hypersensitivity to tranexamic acidAcquired defective color visionHistory of venous thromboembolismPre-existing medical conditions (diabetes mellitus, hypertension, renal disease)SmokersRefused to participate in the trial

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05688111). StuddyBuddy aggregates publicly available trial information.